VELETRI PACKAGE INSERT PDF

VELETRI should not be used chronically in patients who during dose initiation develop pulmonary edema, which may be associated with pulmonary veno-occlusive disease. VELETRI is also contraindicated in patients with known hypersensitivity to the drug or to structurally related compounds. Each vial is for single use only; discard any unused solution. Use after reconstitution and immediate dilution to final concentration.

Author:Grokus JoJoshura
Country:Cape Verde
Language:English (Spanish)
Genre:Video
Published (Last):25 August 2012
Pages:134
PDF File Size:9.63 Mb
ePub File Size:18.32 Mb
ISBN:968-9-63161-347-2
Downloads:39673
Price:Free* [*Free Regsitration Required]
Uploader:Shaktitilar



VELETRI should not be used if you have heart failure due to severe left heart disease, if you develop fluid in the lungs pulmonary edema when starting therapy, or if you are allergic to epoprostenol. Please talk to your doctor about all of your medications. Each vial is for single use only; discard any unused medication. When you take epoprostenol for the first time, you must be in a setting hospital or clinic where you can be monitored for any serious side effects or in case of emergency.

Your blood pressure and heart rate should also be monitored with any dose changes. It is the use of these medications concomitantly in combination with VELETRI that may potentially cause an increase in the risk of bleeding. It is used to treat adults with certain kinds of severe pulmonary arterial hypertension PAH WHO Group 1 , a condition in which blood pressure is too high in the blood vessels between the heart and the lungs.

In these patients, PAH was caused by unidentified or hereditary factors or connective tissue disease. Sudden and dramatic changes in dose may lead to unstable blood pressure, a return of pulmonary hypertension symptoms, or fatal low blood pressure hypotension. To reduce the risk of infection in the bloodstream, it is important to know how to properly care for the catheter and infusion pump.

You may have side effects at the start of treatment or with dose increases. Talk to your doctor if you have any side effect that bothers you or that does not go away. For more information, ask your doctor or pharmacist.

Call your doctor for medical advice about side effects. Please see full Prescribing Information. All rights reserved.

ESCENAS Y TIPOS MATRITENSES PDF

[email protected]: FDA-Approved Drugs

VELETRI should not be used if you have heart failure due to severe left heart disease, if you develop fluid in the lungs pulmonary edema when starting therapy, or if you are allergic to epoprostenol. Please talk to your doctor about all of your medications. Each vial is for single use only; discard any unused medication. When you take epoprostenol for the first time, you must be in a setting hospital or clinic where you can be monitored for any serious side effects or in case of emergency. Your blood pressure and heart rate should also be monitored with any dose changes.

CYBEROAM CR 50IA PDF

I.V. therapy made a little easier

The new 0. Until the newly approved formulation and vial strength become available, patients should continue to use VELETRI according to the current package insert, which can be found at www. VELETRI should not be used chronically in patients who develop pulmonary edema during dose initiation which may be associated with pulmonary veno-occlusive disease. During dose initiation, asymptomatic increases in pulmonary artery pressure coincident with increases in cardiac output occurred rarely.

ALBERT CAMUS CREATE DANGEROUSLY PDF

FDA Approves Actelion Pharmaceuticals US, Inc.'s SNDA for Second Generation VELETRI for Injection

.

EATON M22-I2 PDF

.

Related Articles